An open label phase II study of total neoadjuvant therapy (TNT) consisting of FLOT with pembrolizumab and short radiation for patients with locally advanced gastroesophageal junction adenocarcinoma (EPOC2301)
Year: 2025
Type: article
Language: en
Topic: Esophageal Cancer Research and Treatment
Authors and affiliations:
raw_author_name: K. Sato
raw_affiliation_strings: Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: I. Nakayama
raw_affiliation_strings: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: M. Yura
raw_affiliation_strings: Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: A. Sato
raw_affiliation_strings: Department of Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: M. Suzuki
raw_affiliation_strings: Department of Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: T. Kadota
raw_affiliation_strings: Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: M. Nakamura
raw_affiliation_strings: Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: N. Sakamoto
raw_affiliation_strings: Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: T. Hashimoto
raw_affiliation_strings: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: S. Sakashita
raw_affiliation_strings: Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: M. Wakabayashi
raw_affiliation_strings: Department of Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: H. Shoji
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: T. Hayashi
raw_affiliation_strings: Department of Gastric Surgery, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: H. Daiko
raw_affiliation_strings: Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: K. Kato
raw_affiliation_strings: Department of Gastrointestinal Medical Oncology, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan
raw_author_name: T. Yoshino
raw_affiliation_strings: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: T. Yano
raw_affiliation_strings: Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: T. Fujita
raw_affiliation_strings: Division of Esophageal Surgery, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: T. Kinoshita
raw_affiliation_strings: Department of Gastric Surgery, National Cancer Center Hospital East, Kashiwa, Japan
raw_author_name: K. Shitara
raw_affiliation_strings: Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan